检索结果-南通市图书馆

World Journal of Gastroenterology 2007年第12期13卷 1788-1793页

作者： ming-quan song jin-shui zhu jin-lian chen long wang wei da li zhu wei-ping zhang Department of Gastroenterology The Sixth Affiliated Hospital of Shanghai Jiaotong University Shanghai 200233 China

AIM: To investigate the synergistic effect of oxymatrine(OM) and angiogenesis inhibitor NM-3 on modulatingapoptosis in human gastric cancer cell lines SGC-7901,MKN-45, MKN-74. METHODS: Human gastric cancer lines SGC-7901,MKN-45, MKN-74 were treated with OM in the absenceand presence of NM-3. The inhibitory rates weredetected by MTT assay. Synergistic effect of OM andNM-3 on the growth of survivin, bcl-2, bax and p53 inSGC-7901 cells were examined by semiquantitative RT-PCR and Western blotting, and their growth inhibitoryeffects were also observed on SGC-7901 tumor xenograftin nude ***: OM combined with NM-3 exhibited asynergistic inhibitory effect on the growth of SGC-7901,MKN-45 and MKN-74 cells in a time-dependent ***-four hours after treatment with OM, NM-3 aloneand their combination, mRNA expression of survivin andbcl-2 in SGC-7901 cells decreased, p53 mRNA expressionincreased. OM (4 g/L) combined with NM-3 significantlyincreased the expression of p53 mRNA and decreasedthe expression of survivin and bcl-2 compared witheither agent alone (193% ± 34% vs 129% ± 12%;44% ± 18% vs 92% ± 18%; 36 ± 17% vs 93% ± 23%,P dance with their ***, OM/NM-3 combination obviously exhibitedantitumor growth effect in xenografted human gastriccancer cells SGC-7901 compared with either agent ***: OM combined with NM-3 has synergisticinhibitory effects on human gastric cancer cells in vitro and can suppress the growth of xenografted human gastric cancer cells SGC-7901 in vivo.

关键词： NM-3 compound Oxymatrine Gastric cancer Apoptosis

Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2006年第43期12卷 6949-6954页

作者： long wang jin-shui zhu ming-quan song Guo-Qiang chen jin-lian chen Department of Gastroenterology Sixth People's Hospital Affiliatedto Shanghai Jiaotong University Shanghai 200233 China Shanghai Experimental Animal Centre Chinese Academy of Sciences Shanghai 200233 China

AIM. To study the differential gene expression profiles of target cells in primary gastric cancer and its metastatic lymph nodes using laser microdissection （LMD） in combination with cDNA microarray. METHODS： Normal gastric tissue samples from 30 healthy individuals, 36 cancer tissue samples from primary gastric carcinoma and lymph node metastasis tissue samples from 58 patients during gastric cancer resection were obtained using LMD in combination with cDNA microarray independently. After P27-based amplification, aRNA from 36 of 58 patients （group 1） with lymph node metastasis and metastatic tissue specimens from the remaining 22 patients （group 2） were applied to cDNA microarray. Semiquantitative reverse transcriptase polymerase chain reaction （RT-PCR） and imrnunohistochemical assay verified the results of microarray in group 2 and further identified genes differentially expressed in the progression of gastric cancer. RESULTS： The expression of 10 genes was up-regulated while the expression of 15 genes was down-regulated in 22 gastric carcinoma samples compared with that of genes in the normal controls. The results were confirmed at the level of mRNA and protein, and suggested that four genes （OPCML, RNASE1, YES1 and ACK1） could play a key role in the tumorigenesis and metastasis of gastric cancer. The expression pattern of 3 genes （OPCML, RNASE1 and YES1） was similar to tumor suppressor genes. For example, the expression level of these genes was the highest in normal gastric epithelium, which was decreased in primary carcinoma, and further decreased in metastatic lymph nodes. On the contrary, the expression pattern of gene ACK1 was similar to that of oncogene. Four genes were further identified as differentially expressed genes in the majority of the cases in the progression of gastric cancer. CONCLUSION： LMD in combination with cDNA microaro ray provides a unique support foe the identification of early expression profiles of differential genes and the expr

关键词： Gastric cancer cDNA microarray Laser microdissection Reverse transcriptase polymerase chain reaction P27

The Lyman-alpha Solar Telescope(LST) for the ASO-S mission——Ⅱ. design of LST

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Research in Astronomy and Astrophysics 2019年第11期19卷 33-48页

作者： Bo chen Hui li Ke-Fei song quan-Feng Guo Pei-Jie zhang ling-ping He Shuang dai Xiao-Dong wang Hai-Feng wang Chun-long liu Hong-Ji zhang Guang zhang Yunqi wang Shi-Jie liu Hong-Xin zhang Lei liu Shi-Lei Mao Yang liu Jia-Hao Peng Peng wang liang Sun Yang liu Zhen-wei Han Yan-long wang Kun Wu Guang-Xing Ding Peng Zhou Xin Zheng ming-Yi Xia Qing-Wen Wu jin-Jiang Xie Ya chen Shu-Mei song Hong wang Bo zhu Chang-Bo Chu Wen-Gang Yang li Feng Yu Huang wei-Qun Gan Ying li jing-wei li Lei Lu Jian-Chao Xue Bei-li Ying ming-Zhe Sun cheng zhu wei-Min Bao Lei Deng Zeng-Shan Yin Changchun Institute of Optics FineMechanics and PhysicsChinese Academy of SciencesChangchun 130033China State Key Laboratory of Applied Optics Changchun 130033China Key Laboratory of dark Matter and Space Astronomy Purple Mountain ObservatoryChinese Academy of SciencesNanjing 210034China School of Astronomy and Space Science University of Science and Technology of ChinaHefei 230026China Xi’an Institute of Optics and Precision Mechanics Chinese Academy of SciencesXi’an 710119China Shandong University Weihai 264209China Innovation Academy for Microsatellites Chinese Academy of SciencesShanghai 201210China

As one of the three payloads for the Advanced Space-based Solar Observatory(ASO-S)mission,the Lyman-alpha(Lyα)Solar Telescope(LST)is composed of three instruments:a Solar Corona Imager(SCI),a LyαSolar Disk Imager(SDI)and a full-disk White-light Solar Telescope(WST).When working in-orbit,LST will simultaneously perform high-resolution imaging observations of all regions from the solar disk to the inner corona up to 2.5 R⊙(R⊙stands for the mean solar radius)with a spatial resolution of 4.8′′and 1.2′′for coronal and disk observations,respectively,and a temporal resolution of 30–120 s and 1–120 s for coronal and disk observations,*** maximum exposure time can be up to20 s due to precise pointing and image stabilization *** the three telescopes of LST,SCI is a dual-waveband coronagraph simultaneously and independently observing the inner corona in the HI Lyα(121.6±10 nm)line and white light(WL)(700±40 nm)wavebands by using a narrowband Lyαbeam splitter and has a field of view(FOV)from 1.1 to 2.5 R⊙.The stray-light suppression level can attainline and 360.0 nm wavebands,respectively,which adopt an off-axis two-mirror reflective structure with an FOV up to 1.2 R⊙,covering the inner coronal edge area and relating to coronal *** present the up-to-date design for the LST payload.

关键词： telescopes—instrumentation high angular resolution—Sun flares—Sun coronal mass ejections(CMEs)—Sun UV radiation

三联疗法对非糜烂性反流病合并H pylori感染患者预后的影响

在线全文

学校读者我要写书评

暂无评论

世界华人消化杂志 2006年第19期14卷 1924-1927页

作者：朱金水宋明全朱励王龙陈金联达炜孙群王如华上海交通大学附属第六人民医院消化科上海市200233

目的：探讨幽门螺杆菌(H pylori)根除对非糜烂性反流病(non-erosive reflux diseage,NERD)合并H pylori感染患者疗效及预后．方法：120例非糜烂性反流病合并H pylori感染患者随机分为：对照组60例,仅口服洛赛克(20 mg,2次/d)1 wk；三联... 详细信息

目的：探讨幽门螺杆菌(H pylori)根除对非糜烂性反流病(non-erosive reflux diseage,NERD)合并H pylori感染患者疗效及预后．方法：120例非糜烂性反流病合并H pylori感染患者随机分为：对照组60例,仅口服洛赛克(20 mg,2次/d)1 wk；三联疗法组60例：口服洛赛克(20 mg)和克拉霉素(500 mg)及阿莫西林(500 mg),均每天2次,连续1 wk,1 wk后非糜烂性症状缓解患者,开始口服洛赛克20 mg/d的维持治疗阶段至3 wk：试验结束后6 mo均行胃镜复查及^(13)C呼气试验．结果：试验结束后三联疗法组57例患者H pylori阴性(95．0%),对照组5例转阴(8．3%),两组H pylori根除率差异显著(P＜0．01)；对照组患者残胃萎缩及残胃肠化较H pylori根除组明显增多(P＜0．05),三联疗法但对反流症状烧灼感及进食后梗阻或异物感的改善不明显(P＞0．05)结论：三联疗法根除H pylori后对非糜烂性反流病合并H pylori感染患者的胃窦部的肠化生及不典型增生有防治疗效,但对反流症状烧灼感及进食后梗阻或异物感的改善不明显．

关键词：三联疗法 Hpylori根除非糜烂性反流病疗效

The first data release(DR1) of the LAMOST regular survey

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Research in Astronomy and Astrophysics 2015年第8期15卷 1095-1124页

作者： A-li Luo Yong-Heng Zhao Gang Zhao li-Cai Deng Xiao-wei liu Yi-Peng jing Gang wang Hao-Tong zhang Jian-Rong Shi Xiang-Qun Cui Yao-quan Chu Guo-ping li Zhong-Rui Bai Yue Wu Yan Cai Shu-Yun Cao Zi-Huang Cao Jeffrey L.Carlin Hai-Yuan chen Jian-Jun chen Kun-Xin chen li chen Xue-Lei chen Xiao-Yan chen Ying chen Norbert Christlieb Jia-Ru Chu chen-Zhou Cui Yi-Qiao Dong Bing Du Dong-wei Fan Lei Feng Jian-Ning Fu Peng Gao Xue-Fei Gong Bo-Zhong Gu Yan-Xin Guo Zhan-Wen Han Bo-liang He jin-liang Hou Yong-Hui Hou Wen Hou Hong-zhuan Hu Ning-Sheng Hu Zhong-Wen Hu Zhi-Ying Huo Lei Jia Fang-Hua Jiang Xiang Jiang Zhi-Bo Jiang Ge jin Xiao Kong Xu Kong Ya-Juan Lei Ai-Hua li Chang-Hua li Guang-wei li Hai-Ning li Jian li Qi li Shuang li Sha-Sha li Xin-Nan li Yan li Yin-Bi li Ye-ping li Yuan liang Chien-cheng lin Chao liu Gen-Rong liu Guan-Qun liu Zhi-Gang liu Wen-Zhi Lu Yu Luo Yin-Dun Mao Heidi Newberg Ji-Jun Ni Zhao-Xiang Qi Yong-Jun Qi Shi-Yin Shen Huo-ming Shi jing song Yi-Han song Ding-Qiang Su Hong-Jun Su Zheng-Hong Tang Qing-Sheng Tao Yuan Tian dan wang da-Qi wang Feng-Fei wang Guo-Min wang Hai wang Hong-Chi wang Jian wang Jia-Ning wang Jian-ling wang Jian-ping wang Jun-Xian wang Lei wang Meng-Xin wang Shou-Guan wang Shu-Qing wang Xia wang Ya-Nan wang You wang Yue-Fei wang You-Fen wang Peng wei ming-Zhi wei Hong Wu Ke-Fei Wu Xue-Bing Wu Yu-Zhong Wu Xiao-Zheng Xing ling-Zhe Xu Xin-Qi Xu Yan Xu Tai-Sheng Yan De-Hua Yang Hai-Feng Yang Hui-Qin Yang ming Yang Zheng-Qiu Yao Yong Yu Hui Yuan Hai-Bo Yuan Hai-long Yuan wei-Min Yuan Chao Zhai En-Peng zhang Hua-wei zhang Jian-Nan zhang li-Pin zhang wei zhang Yong zhang Yan-Xia zhang Zheng-Chao zhang ming Zhao Fang Zhou Xu Zhou Jie zhu Yong-Tian zhu Si-cheng Zou Fang Zuo National Astronomical Observatories Chinese Academy of Sciences Department of Astronomy Peking University Shanghai Astronomical Observatory Chinese Academy of Sciences Nanjing Institute of Astronomical Optics & Technology National Astronomical ObservatoriesChinese Academy of Sciences University of Science and Technology of China Department of Physics Applied Physics and AstronomyRensselaer Polytechnic InstituteTroyNY 12180USA Department of Physics and Astronomy Earlham CollegeRichmondIN 47374USA Universitt Heidelberg Zentrum für AstronomieLandessternwarteKnigstuhl 1269117 HeidelbergGermany Department of Astronomy Beijing Normal University Yunnan Observatories Chinese Academy of Sciences Purple Mountain Observatory Chinese Academy of Sciences

The Large sky Area Multi-Object Fiber Spectroscopic Telescope（LAMOST） general survey is a spectroscopic survey that will eventually cover approximately half of the celestial sphere and collect 10 million spectra of stars, galaxies and QSOs. Objects in both the pilot survey and the first year regular survey are included in the LAMOST DR1. The pilot survey started in October 2011 and ended in June 2012, and the data have been released to the public as the LAMOST Pilot data Release in August 2012. The regular survey started in September 2012, and completed its first year of operation in June 2013. The LAMOST DR1 includes a total of 1202 plates containing 2 955 336 spectra, of which 1 790 879 spectra have observed signalto-noise ratio（SNR） ≥ 10. All data with SNR ≥ 2 are formally released as LAMOST DR1 under the LAMOST data policy. This data release contains a total of 2 204 696 spectra, of which 1 944 329 are stellar spectra, 12 082 are galaxy spectra and 5017 are quasars. The DR1 not only includes spectra, but also three stellar catalogs with measured parameters： late A,FGK-type stars with high quality spectra（1 061 918 entries）, A-type stars（100 073 entries）, and M-type stars（121 522 entries）. This paper introduces the survey design, the observational and instrumental limitations, data reduction and analysis, and some caveats. A description of the FITS structure of spectral files and parameter catalogs is also provided.

关键词： techniques: spectroscopic survey—data release—catalog

Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma:A single-arm, multicenter, prospective study

在线全文

学校读者我要写书评

暂无评论

Hepatobiliary & Pancreatic Diseases International 2022年第2期21卷 106-112页

作者： Ren-Yi Su Sun-Bin ling Qiao-Nan Shan Xu-Yong wei Rui wang Chang-Ku Jia li zhuang Tian Shen li-Min Ding Zhi-dan Xu Lai-Bang Luo li-Bo Sun Guang-ming li Tai-Shi Fang Nan Jiang Kun zhang Zhao-Jie Su Zhi-Hai Peng Ren Lang Tao Jiang Qiang He lin-Sen Ye Yang Yang Yu-Ting He Wen-Zhi Guo liu-Gen Lan Xu-Yong Sun Dong chen Zhi-shui chen da-wei Zhou Shao-Jun Ye Qi-Fa Ye Min Tian Jian-Hua Shi Bo wang Jiang liu Qian Lu wei Rao jin-Zhen Cai Tao Lv Jia-Yin Yang Pu-Sen wang lin Zhong jing-Sheng Ma Qi-Gen li Sheng-Dong Wu Chang-Jiang Lu Cai-De Lu Dong-Hua zhang Xuan wang Zi-Qiang li Mu-Jian Teng Jun-Jie li Wen-Tao Jiang Jian-Hua li quan-Bao zhang Ning-Qi zhu Zheng-Xin wang Kang He Qiang Xia Shao-Hua song Zhi-Ren Fu wei Qiu Guo-Yue Lv Rui-Peng song Ji-Zhou wang Zheng wang Jian Zhou Gang chen Ying-Peng Zhao li li Ze-Min Hu Qi-Jie Luo Zhong-Zhou Si Bin Xie Xiao-Shun He Zhi-Yong Guo Shu-Sen Zheng Xiao Xu Department of Hepatobiliary and Pancreatic Surgery The Center for Integrated Oncology and Precision MedicineAffiliated Hangzhou First People’s HospitalZhejiang University School of MedicineHangzhou 310006China NHC Key Laboratory of Combined Multi-organ Transplantation Hangzhou 310003China Department of Hepatobiliary and Pancreatic Surgery Shulan(Hangzhou)HospitalZhejiang Shuren University School of MedicineHangzhou 310022China Department of Hepatobiliary and Pancreatic Surgery The First Affiliated HospitalZhejiang University School of MedicineHangzhou 310003China Department of Transplantation Jiangxi Provincial People’s Hospital Affiliated to Nanchang UniversityNanchang 330006China liver Transplantation Center Beijing You’an HospitalCapital Medical UniversityBeijing 100069China Department of Hepatic Surgery National Clinical Research Center for Infectious DiseaseShenzhen Third People’s HospitalThe Second Affiliated Hospital of Southern University of Science and TechnologyShenzhen 518112China Department of General Surgery Xiang’an Hospital of Xiamen UniversityXiamen 361000China Deartment of Hepatobiliary and Pancreaticosplenic Surgery Beijing Chaoyang HospitalCapital Medical UniversityBeijing 100020China Department of Hepatic Surgery and liver Transplantation Center The Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhou 510630China Department of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Zhengzhou UniversityZhengzhou 450052China Department of liver Transplantation The Second Affiliated Hospital of Guangxi Medical UniversityNanning 530000China Institute of Organ Transplantation Tongji HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan 430030China Institute of Hepatobiliary Diseases of Wuhan University Transplant Center of Wuhan UniversityHubei Key Laboratory of Medical Technology on TransplantationZhongnan Hospital of Wuhan UniversityWuhan 430071China Department of Hepatobiliary Surgery The First Affiliated Hos

Mammalian target of rapamycin(m TOR) inhibitor as an attractive drug target with promising antitumor effects has been widely investigated. High quality clinical trial has been conducted in liver transplant(LT) recipients in Western countries. However, the pertinent studies in Eastern world are paucity. Therefore, we designed a clinical trial to test whether sirolimus can improve recurrence-free survival(RFS) in hepatocellular carcinoma(HCC) patients beyond the Milan criteria after LT. This is an open-labeled, single-arm, prospective, multicenter, and real-world study aiming to evaluate the clinical outcomes of early switch to sirolimus-based regimens in HCC patients after LT. Patients with a histologically proven HCC and beyond the Milan criteria will be enrolled. The initial immunosuppressant regimens are center-specifc for the frst 4-6 weeks. The following regimens integrated sirolimus into the regimens as a combination therapy with reduced calcineurin inhibitors based on the condition of patients and centers. The study is planned for 4 years in total with a 2-year enrollment period and a 2-year follow-up. We predict that sirolimus conversion regimen will provide survival benefts for patients particular in the key indicator RFS as well as better quality of life. If the trial is conducted successfully, we will have a continued monitoring over a longer follow-up time to estimate indicator of overall survival. We hope that the outcome will provide better evidence for clinical decision-making and revising treatment guidelines based on Chinese population data.

关键词： Sirolimus Immunosuppressive agents Hepatocellular carcinoma liver transplantation Conversion

EAP化疗联合^(60)Co局部放疗对晚期食管癌伴骨转移患者预后及IL-2系统的影响

在线全文

学校读者我要写书评

暂无评论

世界华人消化杂志 2006年第34期14卷 3314-3316页

作者：达炜宋明全孙群朱励张强陈金联王龙王如华朱金水上海交通大学附属第六人民医院消化内科上海市200233

目的:探讨EAP化疗联合60Co局部放疗对晚期食管癌伴骨转移患者预后及IL-2系统的影响.方法:晚期食管癌伴骨转移患者66例,分静脉化疗联合放疗治疗组和静脉化疗对照组.两组患者在治疗前及1疗程后分别检测IL-2,IL-2R和sIL-2R的水平,并观察其... 详细信息

目的:探讨EAP化疗联合60Co局部放疗对晚期食管癌伴骨转移患者预后及IL-2系统的影响.方法:晚期食管癌伴骨转移患者66例,分静脉化疗联合放疗治疗组和静脉化疗对照组.两组患者在治疗前及1疗程后分别检测IL-2,IL-2R和sIL-2R的水平,并观察其近期疗效.结果:治疗组1疗程的近期有效率及1a生存率显著高于对照组(93.93%vs36.36%,P<0.01;90.90%vs54.54%,P<0.01),并且治疗组IL-2,IL-2R,sIL-2R水平显著高于对照组(23.6±3.12,23.1±3.14,771.4±11.32ng/Lvs44.1±4.07,53.2±5.24,123.2±9.34ng/L,P<0.01).结论:经EAP化疗联合60Co局部放疗治疗骨转移晚期食管癌患者,可显著改善了其IL-2免疫系统的失衡,并能提高晚期食管癌伴骨转移患者的骨痛缓解率、近期有效率及生存率.

关键词：食管癌 IL-2系统静脉化疗放疗

CEPC Technical Design Report

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Radiation Detection Technology and Methods 2024年第1期8卷 I0003-I0016,1-1091页

作者： Waleed Abdallah Tiago Carlos Adorno de Freitas Konstantin Afanaciev Shakeel Ahmad Ijaz Ahmed Xiaocong Ai Abid Aleem Wolfgang Altmannshofer Fabio Alves weiming An Rui An daniele Paolo Anderle Stefan Antusch Yasuo Arai Andrej Arbuzov Abdesslam Arhrib Mustafa Ashry Sha Bai Yu Bai Yang Bai Vipul Bairathi Csaba Balazs Philip Bambade Yong Ban Tripamo Bandyopadhyay Shou-Shan Bao Desmond P.Barber Ayse Bat Varvara Batozskaya Subash Chandra Behera Alexander Belyaev Michele Bertucci Xiao-Jun Bi Yuanjie Bi Tianjian Bian Fabrizio Bianchi Thomas Biekotter Michela Biglietti Shalva Bilanishvili Deng Binglin Denis Bodrov Anton Bogomyagkov Serge Bondarenko Stewart Boogert Maarten Boonekamp Marcello Borri Angelo Bosotti Vincent Boudry Mohammed Boukidi Igor Boyko Ivanka Bozovic Giuseppe Bozzi Jean-Claude Brient Anastasiia Budzinskaya Masroor Bukhari Vladimir Bytev Giacomo Cacciapaglia Hua Cai Wenyong Cai Wujun Cai Yijian Cai Yizhou Cai Yuchen Cai Haiying Cai Huacheng Cai Lorenzo Calibbi Junsong Cang Guofu Cao Jianshe Cao Antoine Chance Xuejun Chang Yue Chang Zhe Chang Xinyuan Chang wei Chao Auttakit Chatrabhuti Yimin Che Yuzhi Che Bin chen danping chen Fuqing chen Fusan chen Gang chen Guoming chen Hua-Xing chen Huirun chen jinhui chen Ji-Yuan chen Kai chen Mali chen mingjun chen mingshui chen Ning chen Shanhong chen Shanzhen chen Shao-long chen Shaomin chen Shiqiang chen Tianlu chen wei chen Xiang chen Xiaoyu chen Xin chen Xun chen Xurong chen Ye chen Ying chen Yukai chen Zelin chen Zilin chen Gang chen Boping chen Chunhui chen Hok Chuen cheng Huajie cheng Shan cheng Tongguang cheng Yunlong Chi Pietro Chimenti Wen Han Chiu Guk Cho ming-Chung Chu Xiaotong Chu Ziliang Chu Guglielmo Coloretti Andreas Crivellin Hanhua Cui Xiaohao Cui Zhaoyuan Cui Brunella D'Anzi ling-Yun dai Xinchen dai Xuwen dai Antonio De Maria Nicola De Filippis Christophe De La Taille Francesca De Mori Chiara De Sio Elisa Del Core Shuangxue Deng wei-Tian Deng Zhi Deng Ziyan Deng Bhupal Dev Tang Dewen Biagio Di Micco Ran Ding Siqin Dingl Yadong Ding Haiyi Dong Jianin AGH University of Science and Technology Faculty of Physics and Applied Computer ScienceKrakow Anhui University HefeiAnhui Applied Physics Department Federal Urdu University of ArtsScience and TechnologyIslamabad Banaras Hindu University Institute of ScienceVaranasi Bandirma Onyedi Eylul University Bandirma Beihang University Beijing Beijing Computational Science Research Center Beijing Beijing Conveyi LTD Beijing Beijing Glass Research Institute Co. LtdBeijing Beijing Institute of Technology Beijing Beijing Normal University Beijing Brown University ProvidenceRI Budker Institute of Nuclear Physics Novosibirsk Cadi Ayyad University Laboratory of Fundamental and Applied PhysicsPolydisciplinary FacultyMarrakech Cairo University Giza Center for Theory and Computation National Tsing Hua UniversityHsinchu Central China Normal University WuhanHubei Central South University ChangshaHunan Centro de Fisica Teorica de Particulas Universidade Tecnica de LisboaLisboa chengdu KaitengSifang Digital Radio&TV Equipment Co. LtdChengduSichuan China academy of engineering physics MianyangSichuan China building materials academy Beijing China Center of Advanced Science and Technology Beijing China Institute of Atomic Energy Beijing China Jiliang University HangzhouZhejiang China Nuclear Instrument CO. LTDBeijing China University of Geosciences Beijing China University of Geosciences WuhanHubei China University of Mining and Technology XuzhouJiangsu China West Normal University NanchongSichuan Chongqing University Department of PhysicsChongqing Chulalongkorn University Bangkok City University of Hong Kong Department of PhysicsHong Kong Cockcroft Institute Daresbury Cornell University IthacaNY CPPM(AMU/IPhU&CNRS/INP) Marseille dalian Minzu University DalianLiaoning dalian University of Technology Department of PhysicsDalian Deutsches Elektronen-Synchrotron DESY Hamburg Dzhelepov Laboratory of Nuclear Problems of Joint Institute for Nuclear Research(DLNP jinR) Dubna East China University Of Science And Technol

The Circular Electron Positron Collider(CEPC)is a large scientific project initiated and hosted by China,fostered through extensive collaboration with international *** complex comprises four accelerators:a 30 GeV linac,a 1.1 GeV damping Ring,a Booster capable of achieving energies up to 180 GeV,and a Collider operating at varying energy modes(Z,W,H,and tt).The linac and damping Ring are situated on the surface,while the subterranean Booster and Collider are housed in a 100 km circumference underground tunnel,strategically accommodating future expansion with provisions for a potential Super Proton Proton Collider(SPPC).The CEPC primarily serves as a Higgs *** its baseline design with synchrotron radiation(SR)power of 30 MW per beam,it can achieve a luminosity of 5×10^(34)cm^(-2)s^(-1)per interaction point(IP),resulting in an integrated luminosity of 13 ab^(-1)for two IPs over a decade,producing 2.6 million Higgs *** the SR power to 50 MW per beam expands the CEPC's capability to generate 4.3 million Higgs bosons,facilitating precise measurements of Higgs coupling at sub-percent levels,exceeding the precision expected from the HL-LHC by an order of *** Technical Design Report(TDR)follows the Preliminary Conceptual Design Report(Pre-CDR,2015)and the Conceptual Design Report(CDR,2018),comprehensively detailing the machine's layout,performance metrics,physical design and analysis,technical systems design,R&D and prototyping efforts,and associated civil engineering ***,it includes a cost estimate and a preliminary construction timeline,establishing a framework for forthcoming engineering design phase and site selection *** is anticipated to begin around 2027-2028,pending government approval,with an estimated duration of 8 *** commencement of experiments and data collection could potentially be initiated in the mid-2030s.

关键词： initiated exceeding precise

Mammotome乳腺良性肿块微创旋切术的临床应用

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

中国现代手术学杂志 2005年第6期9卷 433-435页

作者：王先明何劲松朱国献刘跃华陈伟财张家庭李泉水李征毅深圳市第二人民医院乳腺疾病诊疗中心深圳518035

目的探讨B超引导下Mammotome微创旋切系统在乳腺良性肿块切除中的临床应用价值。方法B超引导下应用Mammotome系统对98例296处乳房良性肿块施行微创旋切术。结果所有肿块均被准确、完全切除。每个肿块的切除时间平均为25(15～60)min,平... 详细信息

目的探讨B超引导下Mammotome微创旋切系统在乳腺良性肿块切除中的临床应用价值。方法B超引导下应用Mammotome系统对98例296处乳房良性肿块施行微创旋切术。结果所有肿块均被准确、完全切除。每个肿块的切除时间平均为25(15～60)min,平均旋切次数20(8～32)次,皮肤切口0.2～0.3cm。未出现活动性出血、皮下淤血、感染等并发症。结论B超引导下Mammotome微创旋切系统切除乳房良性肿块,操作简单、准确、安全、创伤小,是一项值得推广的乳腺微创技术。

关键词： Mammotome乳腺微创旋切系统超声引导乳腺肿块

在线全文

学校读者我要写书评

暂无评论

2005年中国城市CO2排放数据集

中国人口·资源与环境 2018年第4期28卷 1-7页

作者：蔡博峰刘晓曼陆军王金南刘红光陈洋陈占明丛建辉崔志鹏代春艳董会娟方恺冯彤郭杰李芬孟凡鑫唐伟王庚哲谢运生张建军阿依吐尔逊·沙木西布买日也木·买买提蔡伟光曾胜常盼陈前利陈振国单钰理丁冠乔独威范敏冯相昭干晓宇高壮飞谷雨何凌昊何姚胡鸣明黄丽珍黄桥贾小平菊春燕蓝菁李爽李松李耀光李照令刘合林刘婧文刘庆燕刘竹逯飞马贤磊欧金沛潘栋沈杨税月孙露谭效时唐敏唐袆祺王柯王思亓王香爱王晓培吴家杰吴雪萍肖连香邢文婷徐丽笑叶瑞克袁子坤张飞云张袆张明张琦峰张曦文张宇赵晶赵胜男郑思伟周来友朱天琦曹丽斌冯乐李栋李一静龙瀛孙瑞红环境保护部环境规划院北京100012 中国科学院大气物理研究所北京100029 南京农业大学公共管理学院江苏南京210095 上海财经大学城市与区域科学学院上海200433 中国人民大学经济学院北京100872 山西大学经济与管理学院山西太原030006 E20环境平台咨询部北京100195 重庆工商大学长江上游经济研究中心重庆400067 上海交通大学环境科学与工程学院上海200240 浙江大学公共管理学院浙江杭州310058 天津大学管理与经济学部天津300072 南京农业大学土地管理学院江苏南京210095 深圳市建筑科学研究院股份有限公司北京研创中心广东深圳518049 华南理工大学环境与能源学院广东广州510006 杭州市环境保护科学研究院环境政策研究中心浙江杭州310014 埃因霍芬理工大学建筑学院荷兰埃因霍芬5616SC 江西省科学院能源研究所江西南昌330000 中国地质大学(北京)土地科学技术学院北京100083 新疆农业大学管理学院新疆乌鲁木齐830052 重庆大学建设管理与房地产学院重庆400044 重庆工商大学财政金融学院重庆400067 东安格利亚大学国际发展学院英国诺维奇NR47TJ 环境保护部环境发展中心北京100029 环境保护部环境与经济政策研究中心北京100029 四川大学建筑与环境学院四川成都610065 浙江工业大学政治与公共管理学院浙江杭州310023 美国绿色建筑委员会城市与社区部北京100085 挪威科技大学工程学院挪威约尔维克2815 北京师范大学统计学院北京100875 青岛科技大学环境学院山东青岛266000 北京大学遥感与地理信息系统研究所北京100871 北京师范大学环境学院北京100875 筑波大学日本筑波305-0005 华中科技大学建筑与城市规划学院湖北武汉430074 美国东北大学工学院美国波士顿02115 河北省环境科学研究院规划所河北石家庄050037 中山大学地理科学与规划学院广东广州北京林业大学环境科学与工程学院北京宁波职业技术学院商贸外语学院浙江宁波重庆工商大学土地管理学院重庆日本国立环境研究所社会环境系统研究中心日本筑波中国船舶重工集团公司第七一四研究所北京重庆工商大学管理学院重庆渭南师范学院化学与材料学院陕西渭南福州大学经济与管理学院福建福州扬州大学环境科学与工程学院江苏扬州中国矿业大学管理学院江苏徐州北京大学城市与环境学院北京内蒙古大学公共管理学院内蒙古呼和浩特江苏大学财经学院江苏镇江赤峰学院资源与环境科学学院内蒙古赤峰新余学院经济管理学院江西新余北京市环境保护科学研究院生态与城市环境研究所北京北京清华同衡规划设计研究院有限公司技术创新中心北京100085 北京大学汇丰商学院英国校区华威大学交叉学科研究方法中心英国牛津100871 清华大学建筑学院北京100062 上海工程技术大学管理学院上海021620

2005年是中国承诺碳减排目标的基准年份,因而也是中国城市碳减排战略制定和近中期低碳转型的基准年份和对照年份。中国城市2005年CO_2排放数据的一致性、全面性和精准性对于中国所有城市和每个具体城市的目标考核和评估都有重要意义。... 详细信息

2005年是中国承诺碳减排目标的基准年份,因而也是中国城市碳减排战略制定和近中期低碳转型的基准年份和对照年份。中国城市2005年CO_2排放数据的一致性、全面性和精准性对于中国所有城市和每个具体城市的目标考核和评估都有重要意义。基于中国高空间分辨率网格数据(CHRED 2.0)、城市层面统计数据以及大量现场调研和走访,建立2005年中国城市CO_2排放数据集,包括工业能源排放、工业过程排放、农业排放、服务业排放、城镇生活排放、农村生活排放、交通排放7个部门的直接排放数据和间接排放数据。该数据集的建立汇总了86名研究人员的工作成果,在企业、城市不同行业与部门、城市工业和城市总化石能源等不同层面进行了大量的交叉验证和数据分析,有效保障了数据的精确性和准确性。结果显示,2005年中国城市碳排放呈现出较大的体量差异和空间格局差异。排放前10的城市几乎比排放后10的城市的排放量高出两个数量级。高排放城市基本都是城市群的核心城市。东部城市直接排放占全国直接排放比例最高,达到44.59%,其次是西部城市21.76%,中部城市22.70%,东北城市10.95%。

关键词：城市 CO 2排放数据集中国高空间分辨率网格